6533b7defe1ef96bd1275f90
RESEARCH PRODUCT
Exosome levels in human body fluids: A tumor marker by themselves?
Stefano FaisAntonio MarcillaClaudia CampanellaCeleste Caruso BavisottoFrancesco CappelloFrancesca ProperziMariantonia Logozzisubject
30030301 basic medicinePharmaceutical ScienceExosomesBioinformaticsExosome03 medical and health sciencesTumor BiomarkersProstate cancer0302 clinical medicineBody FluidNeoplasmsBiomarkers TumorHumansMedicineHigh potentialTumor markerBiomarkers; Body fluids; Early diagnosis; Exosomes; Extracellular vesicles; Follow-up; Prostate cancer; Biomarkers Tumor; Body Fluids; Humans; Neoplasm Recurrence Local; Neoplasms; Exosomes; 3003Prostate cancerSettore BIO/16 - Anatomia Umanabusiness.industryFollow-upHealthy subjectsCancerBiomarkerExtracellular vesiclesEarly diagnosiEarly diagnosismedicine.diseaseMicrovesiclesBody FluidsExosomeBody fluids030104 developmental biology030220 oncology & carcinogenesisNeoplasmExtracellular vesicleNeoplasm Recurrence LocalbusinessBiomarkersHumandescription
Despite considerable research efforts, the finding of reliable tumor biomarkers remains challenging and unresolved. In recent years a novel diagnostic biomedical tool with high potential has been identified in extracellular nanovesicles or exosomes. They are released by the majority of the cells and contain detailed molecular information on the cell of origin including tumor hallmarks. Exosomes can be isolated from easy accessible body fluids, and most importantly, they can provide several biomarkers, with different levels of specificity. Recent clinical evidence shows that the levels of exosomes released into body fluids may themselves represent a predictive/diagnostic of tumors, discriminating cancer patients from healthy subjects. The aim of this review is to highlight these latest challenging findings to provide novel and ground breaking ideas for successful tumor early diagnosis and follow-up. (C) 2016 Elsevier B.V. All rights reserved.
year | journal | country | edition | language |
---|---|---|---|---|
2016-04-21 | European Journal of Pharmaceutical Sciences |